Elisabeth de Darkó
No más puestos en curso
Historial de carrera de Elisabeth de Darkó
Antiguos cargos conocidos de Elisabeth de Darkó.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Yamanouchi Nordic | Director Técnico/Científico/I+D | - | - |
| Consejero General | - | - | |
Valderm ApS
 Valderm ApS Pharmaceuticals: MajorHealth Technology Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark. | Director Ejecutivo | 01/04/2006 | - |
Estadísticas
Internacional
| Dinamarca | 3 |
Operativa
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Valderm ApS
Valderm ApS Pharmaceuticals: MajorHealth Technology Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark. | Health Technology |
| Yamanouchi Nordic |
- Bolsa de valores
- Insiders
- Elisabeth de Darkó
- Experiencia
